This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF1ET, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 180 tablets of Janumet 50-1,000 mg, a medication used to treat type 2 diabetes. The contract has a ceiling value of $6,066.49 and is a firm fixed-price delivery order, with a completion date of December 16, 2024. The contract was awarded on December 13, 2024, and does not have a set-aside designation.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, registered in the System for Award Management (SAM.gov) since 2002. The company specializes in distributing a wide range of medical products, including prescription medications, vaccines, and medical equipment, to federal government agencies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/14/25, 10:05 AM